Ansell Limited (ASX:ANN)
28.08
-0.55 (-1.92%)
At close: Mar 20, 2026
Ansell Market Cap
Ansell has a market cap or net worth of 3.96 billion as of March 20, 2026. Its market cap has decreased by -21.23% in one year.
Market Cap
3.96B
Enterprise Value
4.88B
Revenue
3.01B
Ranking
n/a
PE Ratio
20.16
Stock Price
28.08
Market Cap Chart
Since January 16, 1992, Ansell's market cap has decreased from 5.00B to 3.96B, a decrease of -20.72%. That is a compound annual growth rate of -0.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.96B | -20.61% |
| Dec 31, 2025 | 4.99B | 1.96% |
| Dec 31, 2024 | 4.89B | 56.70% |
| Dec 29, 2023 | 3.12B | -12.08% |
| Dec 30, 2022 | 3.55B | -11.25% |
| Dec 31, 2021 | 4.00B | -10.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 66.57B |
| Sigma Healthcare | 31.98B |
| Pro Medicus | 12.54B |
| Cochlear | 10.77B |
| Sonic Healthcare | 9.92B |
| Ramsay Health Care | 9.15B |
| Telix Pharmaceuticals | 4.32B |
| Mesoblast | 2.66B |